Loading...
Artivion Community
NYSE:AORT Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
Community Investing Ideas
Aging Population And Global Approvals Will Advance Cardiac Devices
Key Takeaways Adoption of innovative products and expansion into new markets are fueling global revenue growth and market share gains, especially in heart valve replacements. Operational efficiency, new regulatory approvals, and product launches are increasing profitability, diversifying earnings, and enhancing future financial flexibility.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
US$44.54
8.0% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
12.16% p.a.
Profit Margin
6.54%
Future PE
84.79x
Share price in 2028
US$54.81